CPHO Chemo exam with correct a swers
| |
Which Chemo age |t is associated with a high risk for hyperse |sitivity reactio |?
A. Methotrexate
B. Carboplati |
C. Cytarabi |e
D. Busulfa | - VERIFIED A |SWER✔✔-B
Before a patie |t is to receive i |trathecal Chemo:
A. E |sure developme |tally appropriate patie |t teachi |g is completed
B. Verify the patie |t's white blood cell cou |t
C. E |sure other chemo age |ts are available to admi |ister
D. Apply LMX cream betwee | L5-L7 - VERIFIED A |SWER✔✔-A
Joh | is a 3-year-old who is scheduled to receive his first subQ i |jectio | of |eupoge |. What would |OT be a |
appropriate strategy to decrease the pai | associated with a SC i |jectio |?
A. Use of ice a |d i |suflo | catheter
B. Use of LMX cream
C. Use of distractio |
D. Use of buffered lidocai |e - VERIFIED A |SWER✔✔-D
The preferred i |tramuscular site for a child wo is three-years-old a |d walks is:
A. Deltoid muscle
B. Vastus lateralis muscle
,C. Ve |togluteal muscle
D. Dorsogluteal muscle - VERIFIED A |SWER✔✔-A
Which stateme |t best describes the |ursi |g assessme |t for pate |cy with a direct-push method of admi |
isteri |g a chemotherapy vesica |t:
A. Assess for blood retur | before the i |fusio |, every 2-5ml, a |d for blood retur | a |d pai | at the e |d of the i |
fusio |
B. Assess for blood retur | before the i |fusio | a |d at the completio | of the i |fusio |
C. Assess for blood retur | before the i |fusio | a |d for pai | at the completio | of the i |fusio |
D. Assess for blood retur | before i |fusio |, every 5-10ml, duri |g the i |fusio |, a |d at the e |d of the i |fusio | -
VERIFIED A |SWER✔✔-A
A strategy to preve |t chemo errors i |cludes:
A. Verificatio | of patie |t's height i | i |ches
B. I |depe |de |t dose calculatio |
C. Use of full trade |ame of the drug
D. Use of abbreviatio |s for drug clarificatio | - VERIFIED A |SWER✔✔-B
Which chemo age |t is associated with a maximum cumulative lifetime dose?
A. Cyclophosphamide
B. Etoposide
C. Dau |orubici |
D. |itroge | mustard - VERIFIED A |SWER✔✔-C
After admi |isteri |g the first drug for a dermatologiv reactio | after peg-Asparagi |ase, Sam starts to
complai | of throat tighte |i |g a |d he starts wheezi |g. The MD orders Epi |iphri |e. What is the preferred
route?
, A. PO
B. Sub-Q
C. IV
D. IM - VERIFIED A |SWER✔✔-D
You are givi |g Doxorubici | peripherally IV push a |d based o | the patie |t's complai |ts a |d loss of blood
retur |, you suspect that the Doxorubici | has extravasated. Your immediate |ursi |g i |terve |tio | will i |volve:
A. SLAPP: Stop the i |fusio |, leave the |eedle, aspirate as much drug as possible, pull the |eedle, provider |
otificatio |
B. SLAPP: Slow the i |fusio |, leave the |eedle, attempt to flush, push the remai |der of the flush i |to the vei
|, pull the |eedle
C. STOP: Stop the i |fusio |, treat the site, o |cology team |otificatio |, provide follow up
D. STOP: Slow the i |fusio |, treat the symptoms, o |cology team |otificatio |, provide follow up - VERIFIED A
|SWER✔✔-A
The immediate temperature applicatio | for a Doxorubici |/Dau |orubici | extravasatio | i |volves:
A. Hot applicatio |
B. Warm applicatio |
C. Cold applicatio |
D. |o |e of the above - VERIFIED A |SWER✔✔-C
The primary goal of phase III cli |ical trials is to determi |e:
A. The efficacy of a |ew age |t i | the treatme |t of specific types of ca |cer a |d to validate toxicity a |d
dosage data
B. The maximum tolerated dose of a | i |vestigatio |al drug or combi |atio | of drugs usi |g a recomme |ded
admi |istratio | schedule a |d to ide |tify dose-limiti |g toxicities
C. The value of a |ew age |t i | relatio | to existi |g treatme |ts
| |
Which Chemo age |t is associated with a high risk for hyperse |sitivity reactio |?
A. Methotrexate
B. Carboplati |
C. Cytarabi |e
D. Busulfa | - VERIFIED A |SWER✔✔-B
Before a patie |t is to receive i |trathecal Chemo:
A. E |sure developme |tally appropriate patie |t teachi |g is completed
B. Verify the patie |t's white blood cell cou |t
C. E |sure other chemo age |ts are available to admi |ister
D. Apply LMX cream betwee | L5-L7 - VERIFIED A |SWER✔✔-A
Joh | is a 3-year-old who is scheduled to receive his first subQ i |jectio | of |eupoge |. What would |OT be a |
appropriate strategy to decrease the pai | associated with a SC i |jectio |?
A. Use of ice a |d i |suflo | catheter
B. Use of LMX cream
C. Use of distractio |
D. Use of buffered lidocai |e - VERIFIED A |SWER✔✔-D
The preferred i |tramuscular site for a child wo is three-years-old a |d walks is:
A. Deltoid muscle
B. Vastus lateralis muscle
,C. Ve |togluteal muscle
D. Dorsogluteal muscle - VERIFIED A |SWER✔✔-A
Which stateme |t best describes the |ursi |g assessme |t for pate |cy with a direct-push method of admi |
isteri |g a chemotherapy vesica |t:
A. Assess for blood retur | before the i |fusio |, every 2-5ml, a |d for blood retur | a |d pai | at the e |d of the i |
fusio |
B. Assess for blood retur | before the i |fusio | a |d at the completio | of the i |fusio |
C. Assess for blood retur | before the i |fusio | a |d for pai | at the completio | of the i |fusio |
D. Assess for blood retur | before i |fusio |, every 5-10ml, duri |g the i |fusio |, a |d at the e |d of the i |fusio | -
VERIFIED A |SWER✔✔-A
A strategy to preve |t chemo errors i |cludes:
A. Verificatio | of patie |t's height i | i |ches
B. I |depe |de |t dose calculatio |
C. Use of full trade |ame of the drug
D. Use of abbreviatio |s for drug clarificatio | - VERIFIED A |SWER✔✔-B
Which chemo age |t is associated with a maximum cumulative lifetime dose?
A. Cyclophosphamide
B. Etoposide
C. Dau |orubici |
D. |itroge | mustard - VERIFIED A |SWER✔✔-C
After admi |isteri |g the first drug for a dermatologiv reactio | after peg-Asparagi |ase, Sam starts to
complai | of throat tighte |i |g a |d he starts wheezi |g. The MD orders Epi |iphri |e. What is the preferred
route?
, A. PO
B. Sub-Q
C. IV
D. IM - VERIFIED A |SWER✔✔-D
You are givi |g Doxorubici | peripherally IV push a |d based o | the patie |t's complai |ts a |d loss of blood
retur |, you suspect that the Doxorubici | has extravasated. Your immediate |ursi |g i |terve |tio | will i |volve:
A. SLAPP: Stop the i |fusio |, leave the |eedle, aspirate as much drug as possible, pull the |eedle, provider |
otificatio |
B. SLAPP: Slow the i |fusio |, leave the |eedle, attempt to flush, push the remai |der of the flush i |to the vei
|, pull the |eedle
C. STOP: Stop the i |fusio |, treat the site, o |cology team |otificatio |, provide follow up
D. STOP: Slow the i |fusio |, treat the symptoms, o |cology team |otificatio |, provide follow up - VERIFIED A
|SWER✔✔-A
The immediate temperature applicatio | for a Doxorubici |/Dau |orubici | extravasatio | i |volves:
A. Hot applicatio |
B. Warm applicatio |
C. Cold applicatio |
D. |o |e of the above - VERIFIED A |SWER✔✔-C
The primary goal of phase III cli |ical trials is to determi |e:
A. The efficacy of a |ew age |t i | the treatme |t of specific types of ca |cer a |d to validate toxicity a |d
dosage data
B. The maximum tolerated dose of a | i |vestigatio |al drug or combi |atio | of drugs usi |g a recomme |ded
admi |istratio | schedule a |d to ide |tify dose-limiti |g toxicities
C. The value of a |ew age |t i | relatio | to existi |g treatme |ts
